International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.

Autor: Raad II; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Hachem R; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Masayuki N; Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States., Datoguia T; Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brazil., Dagher H; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Subbiah V; MD Anderson Cancer Network, UT MD Anderson Cancer Center, Houston, United States.; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States., Siddiqui B; Department of Hematology Oncology, Community Health Network, Indianapolis, United States., Bayle A; Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Somer R; Cooper Medical School of Rowan University, Cooper University Health Care, Camden, United States., Fernández Cruz A; Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain., Gorak E; Department of Hematology Oncology, Baptist Health, Jacksonville, United States., Bhinder A; Department of Hematology/Oncology, Ohio Health Marion, Marion, United States., Mori N; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan., Hamerschlak N; Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brazil., Shelanski S; Banner MD Anderson Cancer Center - North Colorado, Greely, United States., Dragovich T; Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, United States., Vong Kiat YE; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore, Singapore., Fakhreddine S; Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon., Pierre AH; Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Mulanovich V; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Adachi J; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Borjan J; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Granwehr B; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., John T; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Yepez EY; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Torres HA; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Ammakkanavar NR; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States., Yibirin M; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Reyes-Gibby CC; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Pande M; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, United States., Ali N; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Rojo RD; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Ali SM; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Deeba RE; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Chaftari P; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Matsuo T; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan., Ishikawa K; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan., Hasegawa R; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan., Aguado-Noya R; Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., García AG; Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Puchol CT; Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Lee DG; Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, The Catholic University of Korea, Seoul, Republic of Korea., Slavin M; Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia., Teh B; Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia., Arias CA; Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States., Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Malek AE; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Chaftari AM; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States.

Publikováno v: ELife [Elife] 2023 Jan 30; Vol. 12. Date of Electronic Publication: 2023 Jan 30.

Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines.

Autor: Malundo AFG; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Taft Avenue, Ermita, Manila, National Capital Region, Philippines., Abad CLR; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Salamat MSS; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Sandejas JCM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Poblete JB; Department of Medicine, University of the Philippines - Philippine General Hospital, Manila, Philippines., Planta JEG; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Morales SJL; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Gabunada RRW; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Evasan ALM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Cañal JPA; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Santos JA; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Manto JT; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Mercado MEP; Department of Clinical Epidemiology, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines., Rojo RD; College of Medicine, University of the Philippines, Manila, Philippines., Ornos EDB; College of Medicine, University of the Philippines, Manila, Philippines., Alejandria MM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines.

Publikováno v: IJID regions [IJID Reg] 2022 Sep; Vol. 4, pp. 134-142. Date of Electronic Publication: 2022 Jul 14.

Proton Beam Therapy for Esophageal Cancer.

Autor: Solidum JGN; College of Medicine, University of the Philippines Manila, Manila 1000, Metro Manila, Philippines., Rojo RD; College of Medicine, University of the Philippines Manila, Manila 1000, Metro Manila, Philippines., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom St., Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Publikováno v: Cancers [Cancers (Basel)] 2022 Aug 22; Vol. 14 (16). Date of Electronic Publication: 2022 Aug 22.

The molecular heterogeneity of the precancerous breast affects drug efficacy.

Autor: Bhardwaj A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. abhardwaj@mdanderson.org., Rojo RD; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; College of Medicine, University of the Philippines Manila, Quezon City, Philippines., Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Koh A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tachibana K; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bedrosian I; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ibedrosian@mdanderson.org.

Publikováno v: Scientific reports [Sci Rep] 2022 Jul 22; Vol. 12 (1), pp. 12590. Date of Electronic Publication: 2022 Jul 22.

Bibliometric analysis of schistosomiasis research in Southeast Asia (1908-2020).

Autor: Tantengco OAG; College of Medicine, University of the Philippines Manila, Manila, Philippines. Electronic address: ogtantengco@up.edu.ph., Rojo RD; College of Medicine, University of the Philippines Manila, Manila, Philippines.

Publikováno v: Acta tropica [Acta Trop] 2022 Apr; Vol. 228, pp. 106322. Date of Electronic Publication: 2022 Jan 20.